100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
Summary Wk4Assgn.E6630.docx NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychi$7.49
Add to cart
Summary Wk4Assgn.E6630.docx NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychi
3 views 0 purchase
Course
Purdue
Institution
Purdue University
Wk4Assgn.E NRNP 6630 Week Four: Pediatric and Mood Disorders College of Nursing-PMHNP, Walden University NRNP 6630: Psychopathology and Diagnostic Reasoning Introduction Depression in a clinical aspect is defined as a medical and psychiatric illness that causes severe symptoms, including ...
wk4assgne6630docx nrnp 6630 week four pediatric and mood disorders college of nursing pmhnp
walden university nrnp 6630 psychopathology and diagnostic reasoning introduction depression i
Written for
Purdue University
Purdue
All documents for this subject (704)
Seller
Follow
helperatsof1
Reviews received
Content preview
NRNP 6630
Week Four: Pediatric and Mood Disorders
College of Nursing-PMHNP, Walden University
NRNP 6630: Psychopathology and Diagnostic Reasoning
Introduction
Depression in a clinical aspect is defined as a medical and psychiatric illness that causes
severe symptoms, including tiredness, low mood, lack of pleasure, and loss of interest, which
can, in some cases, result in suicidal thoughts. According to SAMHSA, the national incidence
of African American children aged 5 to 11 who are experiencing depression correlates with the
increase in suicide rates seen nationally. In the general population, suicide was ranked as the
10th leading cause of death by people in their age group. Researchers say that children are
susceptible to long-term illnesses such as physical or sexual violence, negligence, the effects of
loss,
bullying, or social stigmatization, as well as well as social tension, predispose them to
developing disorders. The study aims to investigate three solutions for an 8-year-old African
American boy suffering from depression and who displays all the signs and symptoms of the
disease, It would also serve as a measure of how ethically sensitive it is to handle this client, the
client must meet at least five of the criteria stipulated in the most recent edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-5), It is highly important for
PMHPs to use extreme caution when administering psychotropic medications directly to
pediatric patients. This paper would identify the care strategy for treating the eight-year-dosing
, patient, which involves three treatment choices, and clarify the reasoning and assessment of
each treatment approach.
Decision #1
Zoloft is taken orally once a day, while Paxil and Wellbutrin are both given orally twice
a day. The first line of childhood and teen antidepressants was SSRIs (SSRIs for the younger age
groups) (Dwyer and Bloch, 2019). This removes Wellbutrin from consideration from this option.
The drug's manufacturer has not yet been able to do enough clinical trials in pediatrics to
recommend it as a first-line therapy and Furthermore, the medication is also associated with risk
of weight loss and epilepsy (Dwyer and Bloch, 2019). It was announced that Paxil could raise
the risk of suicidal thoughts or suicidal behavior in those under the age of eighteen (Hect and
Hect,
2003). There are no clinical trials proving that show that Paxil is successful in treating
children with MDD (Hect and Hect, 2003). Studies also shown a 3.4% higher suicide rates in
children who were prescribed paroxetine (compared to 1% who were not) (8 out of 647; 1.2
percent). There was no instance of suicide among the patients in the data in these studies.
(Waechter,
2003). Thus, in order to treat the client, I agreed to give him Zoloft 25 mg daily. My target of
Zoloft 25 mg a day is to reduce depressive symptoms with few or no side effects. In the coming
weeks, we will see if there are any side effects. In terms of depressive symptoms, the client
reported having returned to the clinic after four weeks, no improvement was seen. therapeutic
reaction doesn't often appear with a reduced dosage of the drug Sometimes the dosage will
need to be increased before a clinical reaction is shown. Each patient responds differently to
medications. Patient education is important enough that the patient doesn't feel they are the
subject of urgent attention. There have been no side effects in the client's life from the use of
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller helperatsof1. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for $7.49. You're not tied to anything after your purchase.
